AptusBiotech is proactively providing end-to-end service, from aptamer discovery to commercialization, with improved technical solutions and experienced team to accelerate aptamer development for our customers.

In terms of development services, AptusBiotech has built an aptamer development platform, from cell lines to protein, peptides or small molecule selections procedures, providing high quality candidates for pre-clinical trials with an innovative drug development process based on aptamers technology. Additionally, we apply Next Generation Sequencing to maximize aptamer screening using the latest bioinformatic tools.


Toward the mission of “Development through Collaboration”, AptusBiotech is committed to helping customers shorten the timeline for the development of biological drugs based on aptamers, meaningfully lowering R&D costs and providing a continuous support along the discovery process.

CONTAC US for further information, budget or timing:
Contact us